Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
3
×
life sciences
national blog main
national top stories
novartis
3
×
roche
3
×
san francisco top stories
biogen
boston blog main
boston top stories
cancer
drug prices
eli lilly
europe top stories
indiana blog main
indiana top stories
national
new york top stories
san francisco blog main
spinal muscular atrophy
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
avapritinib
bill cassidy
billy dunn
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
caelum biosciences
What
drug
fda
latest
therapy
address
alzheimer’s
approval
approved
approves
atrophy
bio
blueprint
cancer
carries
certain
companies
daily
designed
different
evrysdi
fail
friday
gene
genetic
green
home
increases
intended
lights
liquid
medicine
medicines
muscular
new
oral
pass
patients
pharmaceutical
plan
prescription
Language
unset
Current search:
genentech
×
novartis
×
roche
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More